Download FREE Report Sample
Download Free sampleLiposomes and lipid nanoparticles (LNPs) are similar by design, but slightly different in composition and function. Both are lipid nanoformulations and excellent drug delivery vehicles, transporting cargo of interest within a protective, outer layer of lipids. In application, however, LNPs can take a variety of forms.Innovators in the biopharmaceutical industry have developed a number of ways to improve/augment physiochemical properties and ultimately, the drug-like behavior of pharmacological substances. Amidst other alternatives, lipid nanoparticles and liposomes are the main type.Nanoparticle Drug Delivery Systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.Liposomes and Lipid Nanoparticles are delivery carriers, the primary lipids used to make liposomes or Lipid Nanoparticles are Phospholipids, Pegylated Lipids, Ionizable Lipids (Cationic / Anionic Lipids), Triglycerides, Sphingolipids, Neutral Lipids, etc. In our report, we mainly study the Liposomes and Lipid Nanoparticles (LNP) Contract Manufacturing as delivery carriers.
Lipid Contract Market contains market size and forecasts of Lipid Contract Manufacturing in Global, including the following market information:
The global Lipid Contract Manufacturing market was valued at 1050.2 million in 2021 and is projected to reach US$ 982.5 million by 2028, at a CAGR of -0.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Liposomes Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lipid Contract Manufacturing include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical, Lipoid and Polymun Scientific, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lipid Contract Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lipid Contract Manufacturing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Lipid Contract Manufacturing Market Segment Percentages, by Type, 2021 (%)
Global Lipid Contract Manufacturing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Lipid Contract Manufacturing Market Segment Percentages, by Application, 2021 (%)
Global Lipid Contract Manufacturing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Lipid Contract Manufacturing Market Segment Percentages, By Region and Country, 2021 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
